FENC insider buying and SEC filings, explained
Fennec Pharmaceuticals Inc. · CIK 1211583
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$9.9M
Planned sales (10b5-1)
$2.1M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 15, 2026 | Planned (10b5-1) | Marco Maria Brughera (Director) sold 15,545 shares at $10.29 ($160K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 1, 2026 | Planned (10b5-1) | Rosty Raykov (Former Director) sold 10,000 shares at $12.11 ($121K), marked as a 10b5-1 plan trade. Holdings down 7% to 124,411 shares. | SEC filing Filed Sep 1, 2026 |
| Aug 31, 2026 | Sale | Pierre Sargis Sayad (Chief Medical Officer) sold 12,000 shares at $12.18 ($146K). Holdings down 56% to 9,519 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 31, 2026 |
| Aug 27, 2026 | Planned (10b5-1) | Robert Andrade (CFO) sold 75,000 shares at $11.78 ($884K), marked as a 10b5-1 plan trade. Holdings down 26% to 217,675 shares. | SEC filing Filed Aug 28, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Rosty Raykov (Former Director) sold 10,000 shares at $9.58 ($96K), marked as a 10b5-1 plan trade. Holdings down 7% to 131,633 shares. | SEC filing Filed Aug 4, 2026 |
| Jul 1, 2026 | Planned (10b5-1) | Rosty Raykov (Former Director) sold 9,599 shares at $10.41 ($100K), marked as a 10b5-1 plan trade. Holdings down 6% to 138,855 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 9,747 shares at $9.62 ($94K), marked as a 10b5-1 plan trade. Holdings down 7% to 130,079 shares. | SEC filing Filed Jun 2, 2026 |
| May 11, 2026 | Planned (10b5-1) | Chris A. Rallis (Director) sold 8,346 shares at $7.04 ($59K), marked as a 10b5-1 plan trade. Holdings down 12% to 63,077 shares. | SEC filing Filed May 12, 2026 |
| May 1, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,781 shares at $6.47 ($70K), marked as a 10b5-1 plan trade. Holdings down 8% to 121,451 shares. | SEC filing Filed May 1, 2026 |
| Apr 1, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,946 shares at $6.31 ($69K), marked as a 10b5-1 plan trade. Holdings down 9% to 113,856 shares. | SEC filing Filed Apr 2, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,079 shares at $8.36 ($84K), marked as a 10b5-1 plan trade. Holdings down 9% to 103,996 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 2, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,349 shares at $7.76 ($80K), marked as a 10b5-1 plan trade. Holdings down 10% to 98,477 shares. | SEC filing Filed Feb 2, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,312 shares at $7.60 ($78K), marked as a 10b5-1 plan trade. Holdings down 10% to 88,020 shares. | SEC filing Filed Jan 5, 2026 |
| Dec 24, 2025 | Sale | John Smith Clark II (10% owner) sold 1,000,000 shares indirectly at $7.50 ($7.5M). Indirect holdings down 27% to 2,744,741 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Dec 29, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,000 shares at $7.54 ($75K), marked as a 10b5-1 plan trade. Holdings down 11% to 77,526 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 18, 2025 | Sale | John Smith Clark II (10% owner) sold 19,341 shares indirectly at about $8.79 ($170K). Indirect holdings down 1% to 3,744,741 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Nov 20, 2025 |
| Nov 14–17, 2025 | Sale | John Smith Clark II (10% owner) sold 246,018 shares indirectly between Nov 14, 2025 and Nov 17, 2025 at about $8.28 ($2.0M). Indirect holdings down 6% to 3,764,082 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 4 other reporting owners. | SEC filing Filed Nov 17, 2025 |
| Nov 5, 2025 | Planned (10b5-1) | Rosty Raykov (Director) sold 10,000 shares at $8.10 ($81K), marked as a 10b5-1 plan trade. Holdings down 11% to 82,318 shares. | SEC filing Filed Nov 6, 2025 |
76 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow FENC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.